SMAD2 and the relationship of colorectal cancer to inflammatory bowel disease.

作者: S.S. Mahid , K.S. Minor , B.C. Brangers , G.A. Cobbs , S. Galandiuk

DOI: 10.5301/JBM.2008.785

关键词:

摘要: Abstract Inflammatory bowel diseases (IBDs) affecting the colon [Crohn's disease (CD) and ulcerative colitis (UC)] are associated with an increased risk of colorectal cancer (CRC). Our previous work using oligonucleotide array data indicated that SMAD2 was significantly underexpressed in UC dysplastic tissue compared to benign UC. The aim this current study determine whether single nucleotide polymorphisms (SNPs) within gene IBD dysplasia/cancer. We performed SNP haplotype-based case-control association study. Leukocyte DNA obtained from 489 unrelated Caucasians (158 UC, 175 CD, 71 CRC, 85 controls). Eleven SNPs were genotyped. All 11 Hardy-Weinberg equilibrium control population. Strong linkage disequilibrium observed among nearly all SNPs. There no significant associations between allele or haplotype frequencies. Power calculations good power for single-marker analysis (>0.8) reasonably against effects 0.1-0.15 analysis. not development This incongruity our microarray findings genotype may be attributed mechanisms such as alternative splicing pre-mRNA and/or cross talk other cellular pathways.

参考文章(37)
Daniel K. Podolsky, Inflammatory Bowel Disease New England Journal of Medicine. ,vol. 325, pp. 1008- 1016 ,(1991) , 10.1056/NEJM199110033251406
Gabor T. Marth, Ian Korf, Mark D. Yandell, Raymond T. Yeh, Zhijie Gu, Hamideh Zakeri, Nathan O. Stitziel, LaDeana Hillier, Pui-Yan Kwok, Warren R. Gish, A general approach to single-nucleotide polymorphism discovery Nature Genetics. ,vol. 23, pp. 452- 456 ,(1999) , 10.1038/70570
Rik Derynck, Rosemary J. Akhurst, Allan Balmain, TGF-beta signaling in tumor suppression and cancer progression. Nature Genetics. ,vol. 29, pp. 117- 129 ,(2001) , 10.1038/NG1001-117
Ebbe Langholz, Pia Munkholm, Michael Davidsen, Vibeke Binder, Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. ,vol. 103, pp. 1444- 1451 ,(1992) , 10.1016/0016-5085(92)91163-X
Susumu Itoh, Fumiko Itoh, Marie-José Goumans, Peter ten Dijke, Signaling of transforming growth factor‐β family members through Smad proteins FEBS Journal. ,vol. 267, pp. 6954- 6967 ,(2000) , 10.1046/J.1432-1327.2000.01828.X
Carl-Henrik Heldin, Serhiy Souchelnytskyi, Aristidis Moustakas, Smad regulation in TGF-beta signal transduction. Journal of Cell Science. ,vol. 114, pp. 4359- 4369 ,(2001) , 10.1242/JCS.114.24.4359
Ken Yagi, Daisuke Goto, Toshiaki Hamamoto, Seiichi Takenoshita, Mitsuyasu Kato, Kohei Miyazono, Alternatively Spliced Variant of Smad2 Lacking Exon 3 COMPARISON WITH WILD-TYPE Smad2 AND Smad3 Journal of Biological Chemistry. ,vol. 274, pp. 703- 709 ,(1999) , 10.1074/JBC.274.2.703
J Benhattar, E Saraga, Molecular genetics of dysplasia in ulcerative colitis. European Journal of Cancer. ,vol. 31, pp. 1171- 1173 ,(1995) , 10.1016/0959-8049(95)00142-6
Karen L. Krok, Gary R. Lichtenstein, Colorectal cancer in inflammatory bowel disease. Current Opinion in Gastroenterology. ,vol. 20, pp. 43- 48 ,(2004) , 10.1097/00001574-200401000-00009
Robert D Odze, John Goldblum, Amy Noffsinger, Nada Alsaigh, Lyndo A Rybicki, Franz Fogt, Interobserver Variability in the Diagnosis of Ulcerative Colitis-Associated Dysplasia by Telepathology Modern Pathology. ,vol. 15, pp. 379- 386 ,(2002) , 10.1038/MODPATHOL.3880534